乙氨基的生物降解:当前的知识和未来的方向与机械的见解从omics
Bhavana Pandey1, Anand Kumar Pandey2, Laliteshwari Bhardwaj1
1Molecular Ecology Laboratory, Department of Botany, Institute of Science, Banaras Hindu University, Varanasi, Uttar Pradesh, 221005, India.
Chemosphere
|January 16, 2025
概括
乙氨基 (APAP) 是一个广泛存在的环境污染物. 使用OMIC方法的生物修复提供了一种可持续的策略,以降低APAP并保护生态系统.
科学领域:
- 环境科学 环境科学
- 微生物学 微生物学
- 生物技术是生物技术.
背景情况:
- 乙氨基 (APAP) 是一种常见的止痛药和抗炎药,由于其广泛使用和持久性,越来越多的环境问题.
- 在生态系统中APAP及其副产品的积累对环境和人类健康构成风险.
- 创新和可持续的补救策略对于解决APAP污染至关重要.
研究的目的:
- 审查APAP的生态毒性.
- 探索APAP生物降解途径和影响因素.
- 突出奥米克斯方法在理解APAP整治中的作用.
主要方法:
- 关于APAP生态毒性和生物修复的综合文献综述.
- 对生物降解途径和中间代谢物的分析.
- 整合omics技术 (基因组学,转录组学,蛋白质组学,代谢组学) 用于识别APAP降解剂和酶.
主要成果:
- 生物修复是一种有效,环保和可持续的方法来缓解APAP.
- 奥米克的方法有助于识别APAP降解的微生物,基因和酶.
- 像氨基酶,脱氨基酶,氧化酶和二氧化酶这样的关键酶通过中间体,如4-氨基和化,调解APAP降解.
结论:
- 结合omics数据的多学科方法加快了对APAP生物降解的理解.
- 这一整体战略对于开发有效的APAP污染环境的生物增量过程至关重要.
- 有效的生物修复策略对于降低乙氨基对环境的负担至关重要.
相关概念视频
Drug Biotransformation: Overview
2.3K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.3K
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
136
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
136
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
173
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
173
Phase I Oxidative Reactions: Overview
227
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
227
Pharmacokinetics: Overview
5.5K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
5.5K
Phase II Reactions: Acetylation Reactions
173
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
173


